Speed and scalability are critical for success in animal health biologics. Dr. Zhou Hang, Senior Vice President, Head of BioProcess Research and Development Department of WuXi Biologics, shares how the company leverages CHO platforms, single-use technologies, and digital tools to reduce timelines and costs while ensuring global regulatory compliance. Real-world examples illustrate how these innovations enable rapid commercialization, strengthen supply chains, and support sustainable growth in the veterinary biologics market.

In an increasingly volatile ingredient supply landscape, product innovation is a critical lever for reducing risk and ensuring business continuity. This session will explore how brands can proactively design and reformulate products to lessen dependency on high-risk or scarce ingredients, turning supply challenges into opportunities for growth and resilience.

• Discover how product innovation can reduce reliance on high-risk ingredients through smart reformulation and flexible design choices that preserve quality and brand consistency.
• Learn collaborative strategies for aligning R&D, procurement, and risk teams to drive innovation that supports supply security and long-term resilience.